Login / Signup

Hepatitis B status and associated factors among participants screened for simulated HIV vaccine efficacy trials in Kenya and Uganda.

Yunia MayanjaWasima RidaJoshua KimaniAli SsetalaJuliet MpendoAnnet NanvubyaGaudensia MutuaOmu AnzalaMatt A Price
Published in: PloS one (2023)
HBV prevalence and immunity due to vaccination were low among HIV negative individuals who are eligible for HIV vaccine trials and prevalence varies by age, education level and main occupation. Younger individuals and those recruited from existing cohorts/ clinics have a higher likelihood of having no prior HBV infection. HIV prevention intervention trials are a platform to identify individuals that need HBV vaccination.
Keyphrases